Abstract
Previous animal studies have suggested the potential use of clenbuterol in conjunction with a pharmacological reverse remodelling regimen to induce myocardial recovery in patients with LVAD. The aim of this study is to retrospectively evaluate the effects of clenbuterol on the left ventricular (LV) wall thickness and function in patients who had recovered on LVAD and drug combination therapy.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call